MedTrace Logo

Early Postpartum Intrauterine Device (IUD) Placement

NCT01594476 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2019-01-11

Study results available
· View outcomes & findings →

Summary

Women who have just given birth are at high risk for rapid repeat pregnancy, which can lead to negative consequences during the subsequent pregnancy. Providers have traditionally delayed starting birth control, especially placement of intrauterine devices (IUDs), post-delivery for a number of reasons. The first postpartum visit after a woman has given birth is typically scheduled for 6 weeks after her delivery, during which she is typically provided with her chosen method of birth control. This study will evaluate two different IUD placement times: 3 weeks and 6 weeks after delivery. This will allow the researchers to determine if placement time affects a woman's follow-through obtaining the IUD and keeping it inserted in place. The researchers will also look at bleeding patterns and patient/provider satisfaction with the IUD placement

Conditions

  • Contraception

Interventions

DRUG

Levonorgestrel IUS

20 mcg levonorgestrel per day in intrauterine system for Mirena IUS Copper T intrauterine device

Sponsors & Collaborators

Principal Investigators

  • Maureen Baldwin, MD, MPH · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-04-30
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01594476 on ClinicalTrials.gov